Vitrakvi 100 mg Alternative – Larocent (Larotrectinib) 100 mg Capsule | Incepta Pharmaceuticals

Product Overview

Larocent 100 mg is listed in the supplied Lucent product catalogue. Its proposed active ingredient is Larotrectinib, in capsule form. Manufacturer-specific composition is pending verification; do not rely on this listing for dispensing.

Larocent vs Vitrakvi – Reference Brand Comparison

Vitrakvi is a recognized reference brand associated with Bayer. Larocent is listed on the supplied Lucent products price sheet, attributed by the customer to Incepta Pharmaceuticals Ltd. Matching an active ingredient does not demonstrate bioequivalence, regulatory approval or permission to substitute.

Composition and Product Details

• Listed brand: Larocent
• Generic: Larotrectinib (pending manufacturer confirmation)
• Strength: 100 mg
• Dosage form: Capsule
• Catalogue pack: 12 capsules
• Attributed manufacturer: Incepta Pharmaceuticals Ltd., Bangladesh

Therapeutic Uses and Indications

Larotrectinib is used in selected NTRK fusion-positive solid tumors. These are generic-medicine contexts, not independently confirmed approvals for this particular branded presentation. Exact eligible conditions, biomarkers and combination therapies must be confirmed from the local authorized label.

Mechanism of Action

Larotrectinib inhibits TRK proteins produced by NTRK gene fusions. Individual treatment response depends on the disease, formulation, dosing and patient factors.

Dosage and Administration

The stated 100 mg refers to the strength of the supplied product, not a recommended daily or treatment dose. Administration schedules, preparation, food instructions and monitoring depend on the approved indication and formulation. Use only the dose and schedule prescribed by a qualified clinician. Never change strength or substitute a brand without medical advice.

Contraindications

Contraindications can include hypersensitivity and other medicine-specific conditions. Review the current prescribing information for all absolute restrictions, including relevant pregnancy-related contraindications.

Warnings and Precautions

Potential serious risks and monitoring requirements vary by medicine. Discuss infections, cardiovascular disease, liver and kidney function, other medications and pregnancy plans with the specialist. The official product leaflet determines the required safety monitoring.

Possible Side Effects

Adverse reactions may involve gastrointestinal symptoms, fatigue, laboratory abnormalities, infections or organ-specific toxicity, depending on the active ingredient. The full medicine-specific adverse effect profile, frequency and emergency warning signs must be reviewed in the authorized prescribing information.

Drug Interactions

Prescription drugs, nonprescription medicines, herbal products and some foods may interact with Larotrectinib. A pharmacist or specialist should review all current medicines before treatment.

Pregnancy and Breastfeeding

Some treatments can cause fetal harm or require interruption of breastfeeding. Consult the product-specific label and treating specialist for pregnancy testing, contraception and breastfeeding guidance.

Storage and Handling

Follow the temperature, light protection, cold-chain and handling requirements printed on the actual pack. Do not assume storage conditions from another brand or formulation.

Why Is Larocent Listed as an Alternative to Vitrakvi?

The comparison is provided for product discovery by active ingredient and reference brand. It does not establish pharmaceutical or therapeutic equivalence, biosimilarity, interchangeability or authorization in any country.

Manufacturer Information

Listed manufacturer: Incepta Pharmaceuticals Ltd., Bangladesh
Reference brand: Vitrakvi
Reference company: Bayer
Generic: Larotrectinib
Strength: 100 mg
Pack: 12 capsules

Frequently Asked Questions

What does Larocent contain?

Larotrectinib 100 mg, subject to confirmation against the official brand-specific label.

Is Larocent the same as Vitrakvi?

No automatic equivalence or interchangeability can be inferred from the generic ingredient alone.

Can I use another strength instead?

Only when an authorized clinician specifically directs it.

Is a prescription required?

Yes. Appropriate prescription and specialist supervision are required.

Important Medical Disclaimer

Educational product identification only. Clinical information and product availability require verification against official labeling and destination-country regulatory requirements. No purchase or treatment decision should be based on this page alone.